![BeardBros_BlogImages [Recovered]](data:image/svg+xml;base64,PHN2ZyB2aWV3Qm94PSIwIDAgMjU2MCAyOTIiIHdpZHRoPSIyNTYwIiBoZWlnaHQ9IjI5MiIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48L3N2Zz4=)
Key Takeaways
- Connecticut cannabis tax revenue increased 67%, but overall sales only rose 1.6%, revealing a misleading boom.
- The rise in tax revenue stemmed from a THC-based potency tax, not from increased consumer demand or prices.
- Adult-use sales grew while medical sales declined, reflecting changing consumer preferences in a mature market.
- Starting October 1, Connecticut will replace the THC tax with a flat 10.75% gross receipts tax, affecting how tax revenue aligns with sales.
- Operators should monitor sales volume post-tax change to gauge market response and competitive dynamics with neighboring states.
A 67% jump in Connecticut cannabis tax revenue sounds like a market firing on all cylinders. Pull back the curtain, though, and the story reads very differently. Sales at Connecticut dispensaries were essentially flat. What actually moved was the math behind the state’s THC-based potency tax, and that distinction matters enormously for anyone operating in or watching this market.
This is not a boom story. It is a tax structure story. And Connecticut has already decided to rewrite it.
Here is what the data actually shows, why the current tax system produced this result, and what changes on October 1 when the state scraps its potency-based excise tax entirely.
What Do Connecticut’s Cannabis Sales Numbers Actually Show for 2026?
According to an analysis of Connecticut Department of Consumer Protection data by CT Insider, Connecticut retailers recorded about $95.3 million in combined adult-use and medical cannabis sales from January through April 2026. That represents a 1.6% increase over the same four-month window in 2025. Barely a rounding error.
Breaking that down further tells a more complicated story. Adult-use cannabis sales rose roughly 7% during that period, which is a meaningful gain on its own. Medical cannabis sales, on the other hand, continued their ongoing decline. The two trends largely cancelled each other out, leaving the headline number sitting almost exactly where it was a year ago.
Zooming out to full-year data: total Connecticut cannabis sales slipped from roughly $293 million in 2024 to approximately $290 million in 2025, according to state data. Recreational sales grew by $17.6 million over that period, but a $21 million drop in medical marijuana sales more than wiped out those gains.
Why Are Adult-Use and Medical Sales Moving in Opposite Directions?
Medical cannabis markets tend to shrink as adult-use markets mature. Patients who once had no choice but to register through the medical program now have access to the recreational market, often with fewer requirements and more retail locations to choose from. Connecticut fits that pattern closely.
Adult-use sales growing 7% year-over-year, despite flat overall dollar volume, likely reflects more consumers buying more product at lower prices rather than more dollars flowing through the market. That distinction is central to understanding why the tax number behaves so differently from the sales number.
How Does Connecticut’s THC Potency Tax Actually Work?
Connecticut’s current cannabis excise tax does not work like a standard percentage-based sales tax. The state charges based on THC content, not on the price of the product.
The specific rates, according to CT Insider’s reporting on Connecticut Department of Revenue Services data:
- Cannabis flower: 0.625 cents per milligram of THC
- Edibles: 2.75 cents per milligram of THC
- Other cannabis products: 0.9 cents per milligram of THC
Those potency charges stack on top of Connecticut’s 6.35% state sales tax and a 3% municipal cannabis tax.
What Happens When Cannabis Prices Fall But the Potency Tax Does Not?
The average price per gram of cannabis in Connecticut dropped from $12.51 in March 2024 to $7.22 in March 2026, a decline of more than 40%, according to state data previously analyzed by CT Insider. That is a substantial price compression in a short window.
Under a conventional percentage-based excise tax, falling prices would produce lower tax collections. Under Connecticut’s potency tax, that relationship does not hold. A gram of flower with the same THC content generates the same tax regardless of whether it sells for $12 or $7. As prices fell, the fixed potency tax became a larger share of what consumers actually paid at the register.
That is precisely why Connecticut cannabis tax revenue could jump 67% while dollar sales moved just 1.6%. Consumers bought more volume at lower prices. The potency tax collected more because volume went up. Sales dollars stayed flat because prices came down. Two metrics measuring two different things.
What Is Connecticut Replacing the THC Tax With on October 1st?
Through Public Act 26-8, signed into law May 4th, Connecticut scrapped its THC-based excise tax effective October 1st. In its place, the state is implementing a flat 10.75% excise tax on a retailer’s gross cannabis receipts. The 6.35% state sales tax and 3% municipal cannabis tax will remain. The new gross receipts tax does not apply to medical cannabis sales.
This is a significant structural shift. Under the new model, when prices fall, so does the cannabis excise tax collected. The tax burden becomes directly proportional to what consumers actually spend, rather than to the THC content of the product they buy.
For Connecticut dispensaries competing against Massachusetts, where a flat tax structure has already been in place, this change brings the two markets into closer alignment. Connecticut residents who made the drive to Massachusetts for lower prices now face a more competitive market at home.
What Does the 67% Revenue Jump Tell You About Connecticut’s Cannabis Market Health?
Not much, if taken at face value. That is the core lesson in this data set.
Connecticut cannabis tax revenue rising 67% did not reflect a 67% expansion in consumer demand or operator revenue. It reflected a tax mechanism that is structurally decoupled from retail prices, applied to a market where falling prices drove consumers to buy more volume.
For operators, this distinction matters when benchmarking market health, forecasting revenue, or tracking consumer behavior. Tax collection data and gross sales data answer different questions. Conflating them leads to bad reads on the state of the market.
What Should Connecticut Cannabis Operators Watch After October 1st?
The switch to a gross receipts tax will almost certainly change how Connecticut cannabis tax revenue tracks against sales. Going forward, the two numbers should move together much more closely. If they diverge sharply again, that would be worth examining.
Operators should also watch adult-use sales volume against the prior year once the new tax structure takes effect. If the reduction in effective tax burden at the register translates to meaningfully lower consumer prices, and those lower prices pull buyers back from Massachusetts, Connecticut adult-use sales could see acceleration that has not been visible in the flat headline numbers.
The competitive dynamic with Massachusetts, New York, and Rhode Island remains real. Earlier this year, Connecticut lawmakers themselves described the Northeast cannabis market as an “arms race” over purchase limits, potency rules, and tax structures. Connecticut made a significant move on the tax side. How consumers respond to that change starting October 1 is the next data point worth watching closely.
Frequently Asked Questions
Connecticut’s excise tax is based on THC content per milligram, not on retail price. As cannabis prices fell sharply across the state, consumers bought more volume at lower dollar amounts. The potency tax collected more because volume increased, while total sales dollars stayed nearly flat. These two metrics measure different things.
Connecticut charges 0.625 cents per milligram of THC in flower, 2.75 cents per milligram in edibles, and 0.9 cents per milligram in other cannabis products. These charges apply on top of a 6.35% state sales tax and a 3% municipal cannabis tax.
Connecticut’s new flat cannabis excise tax of 10.75% on gross receipts takes effect October 1, 2026. It replaces the THC-based potency tax and applies to retailers, hybrid retailers, and micro-cultivators. It does not apply to medical cannabis sales.
It is expected to lower the effective tax burden on higher-potency products, which had been carrying the heaviest tax load under the per-milligram structure. Lower effective taxes at the register could translate to lower consumer prices, particularly on products where the potency tax was driving effective tax rates as high as 35%, according to dispensary operators.
